GE HealthCare Technologies Inc [GEHC] stock is trading at $85.59, up 0.27%. An important factor to consider is whether the stock is rising or falling in short-term value. The GEHC shares have gain 1.52% over the last week, with a monthly amount drifted -2.34%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
GE HealthCare Technologies Inc [NASDAQ: GEHC] stock has seen the most recent analyst activity on March 11, 2025, when Goldman upgraded its rating to a Buy and also boosted its price target to $100 from $85. Previously, Jefferies upgraded its rating to Buy on January 08, 2025, and elevated its price target to $103. On September 26, 2024, downgrade downgraded it’s rating to Sell and revised its price target to $74 on the stock. BTIG Research upgraded its rating to a Buy but stick to its price target of $100 on September 18, 2024. JP Morgan initiated its recommendation with a Neutral and recommended $90 as its price target on September 09, 2024. Stifel started tracking with a Buy rating for this stock on August 06, 2024, and assigned it a price target of $100. In a note dated May 30, 2024, Goldman initiated an Neutral rating and provided a target price of $87 on this stock.
GE HealthCare Technologies Inc [GEHC] stock has fluctuated between $74.51 and $94.80 over the past year. Currently, Wall Street analysts expect the stock to reach $92 within the next 12 months. GE HealthCare Technologies Inc [NASDAQ: GEHC] shares were valued at $85.59 at the most recent close of the market. An investor can expect a potential return of 7.49% based on the average GEHC price forecast.
Analyzing the GEHC fundamentals
GE HealthCare Technologies Inc [NASDAQ:GEHC] reported sales of 19.67B for the trailing twelve months, which represents a growth of 2.17%. Gross Profit Margin for this corporation currently stands at 0.42% with Operating Profit Margin at 0.14%, Pretax Profit Margin comes in at 0.13%, and Net Profit Margin reading is 0.1%. To continue investigating profitability, this company’s Return on Assets is posted at 0.06, Equity is 0.25 and Total Capital is 0.11. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.18.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 83.94 points at the first support level, and at 82.30 for the second support level. However, for the 1st resistance point, the stock is sitting at 88.23, and for the 2nd resistance point, it is at 90.88.
Ratios To Look Out For
For context, GE HealthCare Technologies Inc’s Current Ratio is 1.00. On the other hand, the Quick Ratio is 0.79, and the Cash Ratio is 0.3. Considering the valuation of this stock, the price to sales ratio is 1.99, the price to book ratio is 4.63 and price to earnings (TTM) ratio is 19.71.
Transactions by insiders
Recent insider trading involved Newcomb George A., Chief Accounting Officer, that happened on Feb 18 ’25 when 2000.0 shares were sold. CEO, Imaging, Rott Roland completed a deal on Nov 06 ’24 to sell 3577.0 shares. Meanwhile, Officer Roland Rott bought 3577.0 shares on Nov 06 ’24.
